Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

483 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • University Of Iowa Iowa City, Iowa, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Corewell Health William Beaum Hosp Royal Oak, Michigan, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT05964504

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
View all 49 locations
View Trial Details

Related conditions